Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
By BY REBECCA ROBBINS AND CARL ZIMMER
Business
https://ift.tt/3rppqvw
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
New York Times
Molnupiravir (Drug), Coronavirus Omicron Variant, Antibodies, Coronavirus Delta Variant, Clinical Trials, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals)
November 30, 2021 at 11:14PM